Anchorage Capital Group, L.L.C.

In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 17, 2026), Anchorage Capital Group, L.L.C. reported 2 stock positions worth $88.6 million. Its top holding was Sentinelone Class A (S) at 83.6% of the portfolio, followed by Ginkgo Bioworks (DNA, 16.4%). Compared with Q3 2025, it sold out of 1. The biggest sale was an exit from Ardagh Metal Packaging (AMBP).

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0001300714
Portfolio Value
$88.6M (Q4 2025)
SEC Filing
0000905148-26-000874 ↗ filed Feb 17, 2026

Holdings Value

0$100.0M$200.0M$300.0M$400.0M$500.0M Q1 2024: $377.5M Q1 2024 Q2 2024: $316.7M Q2 2024 Q3 2024: $374.8M Q3 2024 Q4 2024: $272.5M Q4 2024 Q1 2025: $239.9M Q1 2025 Q2 2025: $258.7M Q2 2025 Q3 2025: $117.4M Q3 2025 Q4 2025: $88.6M $88.6M Q4 2025 Q1 2026: $436.3M Q1 2026 Q2 2026: $450.5M Q2 2026

Holdings 2 stocks · $88.6M
S Sentinelone Inc. Class A 83.61% 4,937,053 $74.1M No change
DNA Ginkgo Bioworks Holdings Inc. 16.39% 1,746,363 $14.5M No change

Portfolio Sells Q3 2025 → Q4 2025
AMBP Ardagh Metal Packaging SA Sold out 0.00% −4.25

Portfolio Buys Q3 2025 → Q4 2025
None this quarter.

Notes & Other Activity Q3 2025 → Q4 2025
AMPWF Ardagh Metal Packaging -CW26 *W EXP 08/04/202 Sold out 1,245,385 $16Kbefore exit

Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 3$450.5MEQPT, S, DNA
Q1 2026 3$436.3MEQPT, S, DNA
Q4 2025 2$88.6MS, DNA
Q3 2025 3$117.4MS, DNA, AMBP
Q2 2025 5$258.7MS, FYBR, ROIV, DNA, AMBP
Q1 2025 5$239.9MS, FYBR, ROIV, DNA, AMBP
Q4 2024 5$272.5MS, FYBR, ROIV, DNA, AMBP
Q3 2024 5$374.8MFYBR, S, ROIV, DNA, AMBP
Q2 2024 5$316.7MFYBR, S, ROIV, DNA, AMBP
Q1 2024 6$377.5MFYBR, S, DNA, ROIV, AMBP